Vogelbaum, Michael A. http://orcid.org/0000-0002-9833-2374
Parney, Ian F.
Elder, J. Bradley
Cahill, Daniel
Article History
Received: 10 January 2020
Accepted: 14 February 2020
First Online: 21 February 2021
Compliance with ethical standards
:
: Michael A. Vogelbaum has indirect equity and royalty interest in Infuseon Therapeutics and has received honoraria from Celgene and Tocagen. Ian F. Parney has no conflicts to declare. J. Bradley Elder has received honoraria from JNJ, Varian and Medtronic. Daniel P. Cahill has received honoraria and travel reimbursement from Merck, and has served as a consultant for Lilly.
: This article does not contain any new studies with human participants or animals performed by any of the authors.